絞り込み

16639

広告

入院患者18人 特定の抗生物質が効かないVREに感染 奈良 (NHK)

奈良県大和高田市の病院で入院患者18人が、特定の抗生物質が効かないVRE=バンコマイシン耐性腸球菌に感染していたことがわかりました。このうち5人が死亡しましたが...

  1. 新規診断多発性骨髄腫患者に対する導入療法...
  2. 70歳以上の再発・難治性低悪性度非ホジキ...
  3. 若年成人FLT3/ITD変異陽性AMLへ...
  4. 二特異性抗体mosunetuzumabが...

ニュース一覧

「vonoprazan」の検索結果

217件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study.

Gastric acid inhibitor aggravates indomethacin-induced small intestinal injury via reducing Lactobacillus johnsonii.

Atrophic gastritis and chronic diarrhea due to Helicobacter pylori infection in early infancy: A case report.

Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study.

Risk of hemorrhage and stricture significantly increases in elderly patients with proton pump inhibitor (PPI)-resistant reflux esophagitis.

The safety and effectiveness of vonoprazan-based eradication therapy; a prospective post-marketing surveillance.

Vonoprazan-associated Gastric Mucosal Redness: A Report of Four Cases.

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis.

Incidence of Delayed Bleeding among Patients Continuing Antithrombotics during Gastric Endoscopic Submucosal Dissection.

Clinical Characterization of Vonoprazan-Refractory Gastroesophageal Reflux Disease.

Optimizing proton pump inhibitors in treatment: Old and new tricks to improve effectiveness.

Review: Treatment of Helicobacter pylori Infection 2019.

In vivo antiulcer activity, phytochemical exploration, and molecular modelling of the polyphenolic-rich fraction of Crepis sancta extract.

Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori.

Treatment of Helicobacter pylori.

Multidrug resistance in : current state and future directions.

A meta-analysis: the efficacy of vonoprazan for management of post-ESD ulcers compared with PPIs.

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.

[Refractory eosinophilic gastroenteritis with gastritis, duodenal ulcer, and colitis: a case report].

Cost-utility analysis of a 'vonoprazan-first' strategy versus 'esomeprazole- or rabeprazole-first' strategy in GERD.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります